Market Overview:
The global three-dimensional (3-D) organoids market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for 3-D organoids for research and drug discovery purposes, technological advancements in 3-D printing technology, and rising investments by key players in this market. Based on type, the global 3-D organoids market can be segmented into stomach, intestine, liver, pancreas, lung, brain, and kidney. Among these segments, the liver segment is expected to witness the highest growth during the forecast period. This high growth can be attributed to increasing demand for 3-D liver models for drug screening and toxicity studies. Based on application area,,the global 3 D organoidsmarket can be divided into hospital settings,,clinic settings,,and academic institutions/research centers.
 Organoids Industry Outlook.svg)
Product Definition:
Organoids are three-dimensional clumps of cells that can self-organize into miniature organs. They are important for understanding how organs form and function.
Stomach:
Stomach is a muscular tube that extends from the digestive system to capture and digest food. The stomach has an important role in maintaining the required acid level in the digestive tract for proper functioning of the gut bacteria. Stomach also plays an important role in absorbing nutrients from food and it's further transport to intestinal cells.
The global market for stomach, its usage.
Intestine:
Intestine is a hollow organ located in the abdominal cavity. The intestine and it's functions are studied with great interest by scientists as well as physicians all over the world. Intestinal diseases, also known as intestinal disorders or bowel diseases, are one of the major causes of morbidity (illness) worldwide.
Application Insights:
The academic sector accounted for the largest revenue share in 2016 and is expected to continue its dominance over the forecast period. This can be attributed to increasing R&D investments in developing new therapeutic applications for 3-D cell models. For instance, a research study published in 2014 used kidney organoids as a tool to understand renal disease progression. Such studies showcase potential uses of organoid models that can help researchers develop effective therapies for chronic diseases such as diabetes and hypertension.
3-D cell culture systems have wide applications across various research areas including drug discovery & development, toxicology testing, stem cell cultivation and regenerative medicine among others. Increasing R&D investments coupled with technological advancements are anticipated to boost market growth across this segment during the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the increasing incidence of cancer, presence of well-established healthcare facilities, and rising adoption of advanced technologies. Moreover, growing number of research collaborations between universities/research institutes and industry players for developing novel 3D organoids is expected to drive growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period due to untapped opportunities in this region. The availability of low-cost labor and raw materials coupled with government support are some major factors contributing toward regional growth. In addition, increasing medical tourism in emerging economies such as India & China can also be attributed towards high demand for organs from across the globe.
Key Companies: Organoid Technologies Ltd., ArterisIP LLC.
Growth Factors:
- Increasing demand for organoids in research and drug discovery
- Growing number of collaborations between organoid technology providers and pharmaceutical companies
- Rising number of organoid-based drug approvals by regulatory agencies
- Proliferation of 3D bioprinting technologies for the production of organoids
- increasing investment in the field of regenerative medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
Three-dimensional (3-D) Organoids Market Research Report
By Type
Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney
By Application
Hospital, Clinic, Academic
By Companies
STEMCELL Technologies Inc, Definigen, 3Dnamics Inc, Organoid Therapeutics, PeproTech, Inc, THERMO FISHER SCIENTIFIC INC, Corning Incorporated, MERCK KGaA, STEMCELL Technologies Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
125
Number of Tables & Figures
88
Customization Available
Yes, the report can be customized as per your need.
Global Three-dimensional (3-D) Organoids Market Report Segments:
The global Three-dimensional (3-D) Organoids market is segmented on the basis of:
Types
Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Academic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- STEMCELL Technologies Inc
- Definigen
- 3Dnamics Inc
- Organoid Therapeutics
- PeproTech, Inc
- THERMO FISHER SCIENTIFIC INC
- Corning Incorporated
- MERCK KGaA
- STEMCELL Technologies Inc
 Organoids Market Overview.svg)
Highlights of The Three-dimensional (3-D) Organoids Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Stomach
- Intestine
- Liver
- Pancreas
- Lung
- Brain
- Kidney
- By Application:
- Hospital
- Clinic
- Academic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Three-dimensional (3-D) Organoids Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Organoids Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Three-dimensional (3-D) organoids are miniature 3-D structures that can be used to study the development and function of organs. They are made from a variety of materials, including cells, tissues, and scaffolds.
Some of the major players in the three-dimensional (3-d) organoids market are STEMCELL Technologies Inc, Definigen, 3Dnamics Inc, Organoid Therapeutics, PeproTech, Inc, THERMO FISHER SCIENTIFIC INC, Corning Incorporated, MERCK KGaA, STEMCELL Technologies Inc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Three-dimensional (3-D) Organoids Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Three-dimensional (3-D) Organoids Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Three-dimensional (3-D) Organoids Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Three-dimensional (3-D) Organoids Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Three-dimensional (3-D) Organoids Market Size & Forecast, 2018-2028
4.5.1 Three-dimensional (3-D) Organoids Market Size and Y-o-Y Growth
4.5.2 Three-dimensional (3-D) Organoids Market Absolute $ Opportunity
Chapter 5 Global Three-dimensional (3-D) Organoids Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Three-dimensional (3-D) Organoids Market Size Forecast by Type
5.2.1 Stomach
5.2.2 Intestine
5.2.3 Liver
5.2.4 Pancreas
5.2.5 Lung
5.2.6 Brain
5.2.7 Kidney
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Three-dimensional (3-D) Organoids Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Three-dimensional (3-D) Organoids Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Academic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Three-dimensional (3-D) Organoids Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Three-dimensional (3-D) Organoids Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Three-dimensional (3-D) Organoids Analysis and Forecast
9.1 Introduction
9.2 North America Three-dimensional (3-D) Organoids Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Three-dimensional (3-D) Organoids Market Size Forecast by Type
9.6.1 Stomach
9.6.2 Intestine
9.6.3 Liver
9.6.4 Pancreas
9.6.5 Lung
9.6.6 Brain
9.6.7 Kidney
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Three-dimensional (3-D) Organoids Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Academic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Three-dimensional (3-D) Organoids Analysis and Forecast
10.1 Introduction
10.2 Europe Three-dimensional (3-D) Organoids Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Three-dimensional (3-D) Organoids Market Size Forecast by Type
10.6.1 Stomach
10.6.2 Intestine
10.6.3 Liver
10.6.4 Pancreas
10.6.5 Lung
10.6.6 Brain
10.6.7 Kidney
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Three-dimensional (3-D) Organoids Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Academic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Three-dimensional (3-D) Organoids Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Three-dimensional (3-D) Organoids Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Three-dimensional (3-D) Organoids Market Size Forecast by Type
11.6.1 Stomach
11.6.2 Intestine
11.6.3 Liver
11.6.4 Pancreas
11.6.5 Lung
11.6.6 Brain
11.6.7 Kidney
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Three-dimensional (3-D) Organoids Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Academic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Three-dimensional (3-D) Organoids Analysis and Forecast
12.1 Introduction
12.2 Latin America Three-dimensional (3-D) Organoids Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Three-dimensional (3-D) Organoids Market Size Forecast by Type
12.6.1 Stomach
12.6.2 Intestine
12.6.3 Liver
12.6.4 Pancreas
12.6.5 Lung
12.6.6 Brain
12.6.7 Kidney
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Three-dimensional (3-D) Organoids Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Academic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Three-dimensional (3-D) Organoids Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Three-dimensional (3-D) Organoids Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Three-dimensional (3-D) Organoids Market Size Forecast by Type
13.6.1 Stomach
13.6.2 Intestine
13.6.3 Liver
13.6.4 Pancreas
13.6.5 Lung
13.6.6 Brain
13.6.7 Kidney
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Three-dimensional (3-D) Organoids Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Academic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Three-dimensional (3-D) Organoids Market: Competitive Dashboard
14.2 Global Three-dimensional (3-D) Organoids Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 STEMCELL Technologies Inc
14.3.2 Definigen
14.3.3 3Dnamics Inc
14.3.4 Organoid Therapeutics
14.3.5 PeproTech, Inc
14.3.6 THERMO FISHER SCIENTIFIC INC
14.3.7 Corning Incorporated
14.3.8 MERCK KGaA
14.3.9 STEMCELL Technologies Inc
